Author： Oliva José Luis Griner Erin M. Kazanietz Marcelo G.
Publisher： Informa Healthcare
ISSN： 0897-7194
Source： Growth Factors, Vol.23, Iss.4, 2005-12, pp. : 245-252
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Growth factors exert their cellular effects through signal transduction pathways that are initiated by the ligation of growth factors to their cell surface receptors. One of the well-established effectors of growth factor receptors is protein kinase C (PKC), a family of serine-threonine kinases that have been known for years as the main target of the phorbol ester tumor promoters. While there is abundant information regarding downstream PKC effectors and partners, how individual PKC isozymes become activated by growth factors and the regulation of receptor function by PKCs is only partially understood. Moreover, the identification of novel “non-kinase” DAG-binding proteins has added a new level of complexity to the field of DAG signaling.
Related content
Access to resources
Recommend
By Van Lonkhuyzen Derek Hollier Brett Shooter Gary Leavesley David Upton Zee
Growth Factors, Vol. 25, Iss. 5, 2007-10 ,pp. :
By Sagsoz Hakan Ketani Muzaffer Aydin
Growth Factors, Vol. 28, Iss. 6, 2010-12 ,pp. :
By McFarland D.C. Gilkerson K.K. Pesall J.E. Wellenreiter R.H. Ferrin N.H. Ye W.V. Yun Y. Vander Wal L.S.
General and Comparative Endocrinology, Vol. 105, Iss. 1, 1997-01 ,pp. :